Clinical Trial Update: A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) [Phase 3]

View source ↗

Summary

A Phase 3 master protocol trial (SYNERGY-Outcomes) testing multiple agents in adults with metabolic dysfunction-associated fatty liver disease is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Fatty Liver Disease

Snippet

Sponsor: Eli Lilly and Company | Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease | Phase 3 | Status: RECRUITING